London, July 30, 2019 (GLOBE NEWSWIRE) -- According to a new market research report Breast Imaging Market by Technology [Ionizing (FFDM, Analog, 3D Mammogram, PEM, CT, CBCT, EIT), Non-Ionizing (Breast Ultrasound, Breast MRI, AWBU, Breast Thermography)], End User (Hospital, Diagnostic Imaging Center) - Global Forecast to 2024”, published by Meticulous Research®, the global breast imaging market is expected to grow at a CAGR of 8.2% from 2019 to reach $5.13 billion by 2024.

Previously, breast imaging was done using X-ray film, analog or other traditional mammograms; however, these products used to come with drawbacks such as inability to examine dense breast tissue, longer procedure for viewing mammogram, ability to capture only two images of each breast, and less allowance to undergo mammographic examination for woman over age 40. Thus, to overcome these drawbacks, digital mammography came into existence. These digital systems are able to capture tiny calcium deposits which may lead to cancer or any abnormality, with low dosage. Moreover, digital files can be easily enhanced and shared to clinicians at any locations. Most of the women aged 40 year & above prefer to undergo routine mammographic examinations as it is covered by health insurance in most of the countries. Though, there is emergence of digital mammography, not all systems are able to detect abnormalities in dense breast tissue. Therefore, researchers developed new technology called tomosynthesis, which can accurately determine breast cancer from dense breast tissue. Moreover, this technology reduces the patient recall rate up to 30%. Similarly, this technology has comparatively low cost because of less false positive and false negative errors. Such advancements in the breast imaging technology and growing awareness about the timely diagnosis of the disease for better care in women are driving the growth of breast imaging market. In addition, rising prevalence and incidence of breast cancer, increasing investment and funding in R&D for breast cancer treatments, and rising women aging population further drives the growth of the overall breast imaging market.

Request Sample Report:

The breast imaging market is primarily segmented on the basis of technology, end user, and geography. On the basis of technology, the overall breast imaging market is mainly categorized into two segments- Ionizing technology and Non-ionizing technology. The Ionizing technology market is further segmented into Full-Field Digital Mammography (FFDM), analog mammography, 3D Breast Tomosynthesis (DBT), Positron Emission Tomography/Computed Tomography (PET/CT), Molecular Breast-Specific Gamma Imaging (MBI/BSGI), Positron Emission Mammography (PEM), Computed Tomography (CT), Cone Beam Computed Tomography (CBCT), and Electric Impedance Tomography (EIT); whereas,  non-ionizing technology segment is further segmented into breast ultrasound, breast MRI, Automated Whole-Breast Ultrasound (AWBS), breast thermography, and optical imaging.

On the basis of technology, ionizing technology is estimated to command the largest share of the overall breast imaging market in 2019, primarily due to their availability in the market from last many decades and continuous ongoing technological advancements to offer better results. On the other hand, non-ionizing technology is expected to grow at the highest CAGR, owing to their advantages such as enhanced safety, accurate detection of breast tumor location, and higher sensitivity for smaller breast lesion in dense breast women.

On the basis of end user, the overall breast imaging market is mainly categorised into hospitals, diagnostic imaging centers, and ambulatory surgical centres. Hospitals segment is estimated to command the largest share of the global breast imaging market in 2019. The factors such as higher purchasing power of hospitals, well-equipped operating & diagnostic rooms, presence of highly skilled healthcare professionals, better health coverage for hospital based healthcare services from various private and group insurance plans and therefore higher patient visits to hospital settings supported the their largest share of the overall market.

Browse key industry insights spread across 170 pages with 113 market data tables & 61 figures & charts from the report:

Geographically, the global breast imaging market is segmented into North America (U.S. and Canada), Europe (Germany, France, the U.K., Italy, Spain, and RoE), Asia-Pacific (Japan, India, China, and RoAPAC), Latin America, and Middle East & Africa.  With the accelerated economic growth in many countries and growing government focus on healthcare sector, Asia-Pacific breast imaging market is expected to grow at the highest CAGR from 2019 to 2024. In addition, rising incidence & prevalence of breast tumor, increasing health insurance penetration, and growing female aging population further expected to drive the growth of breast imaging market in this region.

The global breast imaging market is dominated by the top three companies- Hologic, Inc. (U.S.), GE Healthcare (U.S.), and Siemens Healthcare GmbH (Germany). These companies are leading the market owing to their strong brand recognition, diverse product basket, robust distribution and sales networks, and strong organic and inorganic growth strategies. Other key players operating in the global breast imaging market are Carestream Health Inc. (U.S.), Koninklijke Philips N.V. (The Netherlands), FUJIFILM Holdings America Corporation (U.S.), Canon Medical Systems Corporation (Japan), Hitachi Medical Systems (U.S.), Aurora healthcare US Corporation (U.S.), Dilon Technologies, Inc. (U.S.), CMR Naviscan Corporation (U.S.), Planmed Oy (Finland), and SonoCine Inc. (U.S.).

Download Free Sample Report @

Related Reports-

Medical Image Management Market by Product (PACS (Radiology, Mammography, Cardiology, Oncology, Enterprise), VNA, AICA, Universal Viewer), Delivery (On Premise, Hybrid, Cloud), End User (Hospitals, Diagnostic Imaging Center, ASC) - Global Forecast to 2024

Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025

About Meticulous Research®

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Mr. Khushal Bombe
Meticulous Research®
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Visit Our Website:
Meticulous Research® Blog:
Connect with us on LinkedIn-